CrossRef Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals Mengjie Hu, Huawei Wang, Zixuan Mei, Cheng Gong, Lan Lan, Zixuan Ma, Binhao Zhang, Haomiao Fan, Yuqing Zhang, He Wang, Wanshun Chun, Dingyu Pan, Jianliang Zhou, Zhen Li Metabolism and Target Organ Damage .2026;[Epub] CrossRef Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunctionassociated steatotic liver disease (MASLD) without cirrhosis Hao-Chien Hung, Po-Jung Hsu, Yin Lai, Wei-Chen Lee, Chen-Fang Lee Annals of Hepatology .2026
[9] [10] Report any suspected side effects to the MHRA Yellow Card scheme upon returning to the UK
We support qualified patients with treatment protocols tailored to fit their personal needs
GLP-1 medications are not for those with a history of Medullary Thyroid Carcinoma or MEN 2